Search details
1.
Real-World Outcomes of Trastuzumab Deruxtecan in Patients With HER2+ Metastatic Breast Cancer: The DE-REAL Study.
Oncologist
; 29(4): 303-310, 2024 Apr 04.
Article
in English
| MEDLINE | ID: mdl-37995313
2.
Immune-related toxicity and soluble profile in patients affected by solid tumors: a network approach.
Cancer Immunol Immunother
; 72(7): 2217-2231, 2023 Jul.
Article
in English
| MEDLINE | ID: mdl-36869232
3.
Post-Progression Treatments after Palbociclib plus Endocrine Therapy in HR+/HER2- Metastatic Breast Cancer Patients: What Is the Better Choice?
Oncology
; 2021 Dec 07.
Article
in English
| MEDLINE | ID: mdl-34875670
4.
Antinuclear antibodies may predict the development of immune-related adverse events in asymptomatic patients treated with immune checkpoint inhibitors: results from a single-center cohort.
Clin Exp Med
; 24(1): 72, 2024 Apr 10.
Article
in English
| MEDLINE | ID: mdl-38598028
5.
PD-L1 testing in metastatic triple negative breast cancer: Results of an Italian survey.
Tumori
; 110(1): 44-48, 2024 Feb.
Article
in English
| MEDLINE | ID: mdl-37726962
6.
Immune responses and clinical outcomes following the third dose of SARS-CoV-2 mRNA-BNT162b2 vaccine in advanced breast cancer patients receiving targeted therapies: a prospective study.
Front Oncol
; 13: 1280416, 2023.
Article
in English
| MEDLINE | ID: mdl-38023235
7.
[Management of the patient with extensive stage microcytoma. The importance of collaboration between oncology and radiotherapy.] / Gestione del paziente con microcitoma a stadio esteso. L'importanza della collaborazione tra oncologia e radioterapia.
Recenti Prog Med
; 114(7): 414-425, 2023.
Article
in Italian
| MEDLINE | ID: mdl-37392104
8.
The Impact of Drug-Drug Interactions on the Toxicity Profile of Combined Treatment with BRAF and MEK Inhibitors in Patients with BRAF-Mutated Metastatic Melanoma.
Cancers (Basel)
; 15(18)2023 Sep 15.
Article
in English
| MEDLINE | ID: mdl-37760556
9.
Pathologic response and survival after neoadjuvant chemotherapy with or without pertuzumab in patients with HER2-positive breast cancer: the Neopearl nationwide collaborative study.
Front Oncol
; 13: 1177681, 2023.
Article
in English
| MEDLINE | ID: mdl-37441419
10.
The role of immune profile in predicting outcomes in cancer patients treated with immunotherapy.
Front Immunol
; 13: 974087, 2022.
Article
in English
| MEDLINE | ID: mdl-36405727
11.
Comparison of Two Blood-Based Genotyping Tests to Investigate the KRAS G12C Mutation in Patients with Non-Small-Cell Lung Cancer at Failure of First-Line Treatments.
Diagnostics (Basel)
; 11(12)2021 Nov 25.
Article
in English
| MEDLINE | ID: mdl-34943432
12.
Role of Chemotherapy in Vulvar Cancers: Time to Rethink Standard of Care?
Cancers (Basel)
; 13(16)2021 Aug 12.
Article
in English
| MEDLINE | ID: mdl-34439215
13.
Tissue Immune Profile: A Tool to Predict Response to Neoadjuvant Therapy in Triple Negative Breast Cancer.
Cancers (Basel)
; 12(9)2020 Sep 16.
Article
in English
| MEDLINE | ID: mdl-32947953
14.
The Strange Case of a Pancreatic Neuroendocrine Carcinoma With Low Proliferation Index and Atypical Clinical Behavior.
Pancreas
; 51(2): e25-e27, 2022 02 01.
Article
in English
| MEDLINE | ID: mdl-35404907
15.
Status of correlation between BMI and response to immunocheck-point inhibitor in advanced non-small-cell lung cancer.
Lung Cancer Manag
; 9(2): LMT26, 2020 Feb 25.
Article
in English
| MEDLINE | ID: mdl-32346402
16.
p38 MAPK activation controls the TLR3-mediated up-regulation of cytotoxicity and cytokine production in human NK cells.
Blood
; 104(13): 4157-64, 2004 Dec 15.
Article
in English
| MEDLINE | ID: mdl-15315972
17.
Src-dependent Syk activation controls CD69-mediated signaling and function on human NK cells.
J Immunol
; 169(1): 68-74, 2002 Jul 01.
Article
in English
| MEDLINE | ID: mdl-12077230
Results
1 -
17
de 17
1
Next >
>>